Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative ColitisSummary

Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative ColitisSummary

Background & Aims: Inflammatory bowel diseases are multifactorial diseases commonly treated with either immunomodulatory drugs or anti–tumor necrosis factor (TNF). Currently, failure to respond to anti-TNF therapy (assessed no earlier than 8–12 weeks after starting treatment) occurs in 20%–4...

Full description

Bibliographic Details
Main Authors:	Marina Liso, Giulio Verna, Elisabetta Cavalcanti, Stefania De Santis, Raffaele Armentano, Angela Tafaro, Antonio Lippolis, Pietro Campiglia, Antonio Gasbarrini, Mauro Mastronardi, Theresa Torres Pizarro, Fabio Cominelli, Loris Riccardo Lopetuso, Marcello Chieppa
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Subjects:	Ulcerative Colitis Cytokines TNF
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X22000522

Similar Items

Deletion of TNF in Winnie-<em>APC<sup>Min/+</sup></em> Mice Reveals Its Dual Role in the Onset and Progression of Colitis-Associated Colorectal Cancer
by: Giulio Verna, et al.
Published: (2022-12-01)

Winnie-<i>APC<sup>Min/+</sup></i> Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation
by: Stefania De Santis, et al.
Published: (2020-04-01)

Epithelially Restricted Interferon Epsilon Protects Against ColitisSummary
by: Eveline D. de Geus, et al.
Published: (2024-01-01)

Enterococcus faecalis Glucosamine Metabolism Exacerbates Experimental ColitisSummary
by: Ting-Jia Fan, et al.
Published: (2021-01-01)

PGI2 Inhibits Intestinal Epithelial Permeability and Apoptosis to Alleviate ColitisSummary
by: Camille Pochard, et al.
Published: (2021-01-01)

Iron-Enriched Nutritional Supplements for the 2030 Pharmacy Shelves
by: Giulio Verna, et al.
Published: (2021-01-01)

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention
by: Cristiano Pagnini, et al.
Published: (2021-09-01)

Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects
by: Stefania De Santis, et al.
Published: (2021-01-01)

INFLIXIMAB AND TUMOUR NECROSIS FACTOR ALPHA MEASUREMENT ON INTESTINAL MUCOSA: A NEW TOOL FOR THE CLINIC?
by: Silvia Pecere, et al.
Published: (2016-12-01)

Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit ColitisSummary
by: Wenjing Yang, et al.
Published: (2023-01-01)

Highly Sensitive, Flow Cytometry-Based Measurement of Intestinal Permeability in Models of Experimental ColitisSummary
by: Kevin Tsai, et al.
Published: (2023-01-01)

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
by: María Florencia Mercogliano, et al.
Published: (2020-04-01)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
by: Loris Riccardo Lopetuso, et al.
Published: (2023-05-01)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
by: Hideki Kitaura, et al.
Published: (2022-01-01)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
by: Grainne Holleran, et al.
Published: (2017-09-01)

Tumor Necrosis Factor: What Is in a Name?
by: Xinming Wang, et al.
Published: (2022-10-01)

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.
Published: (2012-12-01)

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
by: Rosane Dias Costa, et al.
Published: (2013-12-01)

Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
by: Portia Gough, et al.
Published: (2020-11-01)

Tumor necrosis factor alpha of teleosts: in silico characterization and homology modeling
by: Tran Ngoc Tuan, et al.
Published: (2016-10-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Anti-tumor necrosis factor-α is potentially better than tumor necrosis factor-α as the biomarker for sarcopenia: Results from the I-Lan longitudinal aging study
by: Wei-Ju Lin, et al.
Published: (2023-02-01)

Critical role of tumor necrosis factor-α in the early process of wound healing in skin
by: Masae Ritsu, et al.
Published: (2017-01-01)

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2)
by: Ehsan Ghamari, et al.
Published: (2016-01-01)

Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction
by: Alexandre Paccalet, et al.
Published: (2021-09-01)

Production of tumor necrosis factor-á is increased in urinary tract infections
by: Neni Susilaningsih, et al.
Published: (2012-12-01)

Production of tumor necrosis factor-a is increased in urinary tract infections
by: Neni Susilaningsih, et al.
Published: (2015-12-01)

RECOMBINANT PROTEIN OF VARIOLA VIRUS ABOLISHES THE EFFECTS OF TUMOR NECROSIS FACTOR UPON MARROW HEMATOPOIESIS IN BALB/С MICE
by: L. B. Toporkova, et al.
Published: (2014-07-01)

Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study
by: Marina Liso, et al.
Published: (2022-01-01)

Reproductive effects of the tumor necrosis factor (TNF) deficiency in mice
by: S. O. Maslennikova, et al.
Published: (2015-12-01)

Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced ColitisSummary
by: Steffen Pfeuffer, et al.
Published: (2022-01-01)

Angiotensin II‐induced natriuresis is attenuated in knockout mice lacking the receptors for tumor necrosis factor‐α
by: Dewan S. A. Majid, et al.
Published: (2021-08-01)

Tumor necrosis factor alpha gene polymorphism in Serbian patients with sarcoidosis
by: Rađenović-Petković Tatjana, et al.
Published: (2013-01-01)

Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
by: Federica Azzolini, et al.
Published: (2023-05-01)

Increased production of tumor necrosis factor-alpha in whole blood cultures from children with primary malnutrition
by: Z.M.A. Azevedo, et al.
Published: (2005-02-01)

The Role of Tumor Necrosis Factor Alpha in Adolescent Iraqi Children Infected with Toxoplasmasis
by: ashjan Mohammed, et al.
Published: (2024-01-01)

Lymphoma developing in a patient with long-term antitumor necrosis factor therapy
by: Giovana Serrão Fensterseifer, et al.
Published: (2022-07-01)

Prebiotic Enriched Exclusive Enteral Nutrition Suppresses Colitis via Gut Microbiome Modulation and Expansion of Anti-inflammatory T Cells in a Mouse Model of ColitisSummary
by: Genelle R. Healey, et al.
Published: (2021-01-01)

The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study
by: Dalia Shaaban, et al.
Published: (2018-01-01)